News

Presentation at LabRoots 2024

Mar 4, 2024

Martin Shaw, Business Development at AroCell, held a presentation on the Thymidine Kinase 1 immunoassay, highlighting its significance as a valuable translational biomarker from drug discovery through to clinical trials. You can see the presentation below.

Further strengthening partnerships in Southeast Asia

In the beginning of May, IDL Diagnostics team visited our distributors in Indonesia and the Philippines as part of our ongoing efforts to strengthen local partnerships and stay closely connected to our markets. During our time in Jakarta, we had an in-depth discussion...

read more

Gustav Sten appointed CEO of IDL Diagnostics

IDL Diagnostics today announces that the Board of Directors has appointed Gustav Sten as the new Chief Executive Officer (CEO). Gustav Sten will assume the position on May 28, immediately following the Annual General Meeting, succeeding Anders Hultman.  Gustav Sten...

read more